Earlier in the week, I wrote about a cancer vaccine treatment that Stanford pathologist Edgar Engleman, MD, developed in the early 90s. As expected, the FDA gave the vaccine, called Provenge, the thumbs up today; according to Dow Jones (subscription required), the agency approved Provenge for patients with advanced prostate cancer who have failed hormone therapy treatment.
Popular posts
A look at how colds and chronic disease affect DNA expression
Geneticist Michael Snyder has tracked the expression of his genes for three years, focusing on changes in response to chronic or acute disease.
Text from Mom: “Dad won the Nobel Prize”
A late-night phone call informed a Stanford doctor that his father was named a chemistry laureate for work that helped others create drugs from antibodies.